| Title: | A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab in checkpoint inhibitor refractory advanced or unresectable melanoma |
| Authors: | Alexander N. Shoushtari, MD; Anthony J. Olszanski, MD, RPh; Thomas J. Hornyak, MD; Jedd D. Wolchok, MD, PhD; Sylvia Vetrhus; Karianne Risberg Handeland; Lukasz Kuryk, PhD; Magnus Jaderberg, MD; |
| Date: | 9 November 2019 |
| Time: | 5:30 pm – 5:45 pm |
| Presenter: | Dr. Alexander Shoushtari, Principal Investigator, MSKCC, NYC |